DT-13

N/A

Report date: 2025/06/18 14:52:46
NME

Base Information

Drug NameDT-13
Drug Alias NameDT-13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCardiovascular DiseasesBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Medical University
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Tasly Pharmaceutical Co LtdChina Pharmaceutical University
Inactive CompaniesNanjing Medical University
Active IndicationsBreast Neoplasms
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A